日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/04 | 1,835 | 1,846 | 1,835 | 1,838 | +9 | +0.5% | 5,700 |
| 2023/04/03 | 1,839 | 1,840 | 1,829 | 1,829 | -10 | -0.5% | 3,000 |
| 2023/03/31 | 1,841 | 1,847 | 1,816 | 1,839 | -6 | -0.3% | 3,300 |
| 2023/03/30 | 1,876 | 1,876 | 1,835 | 1,845 | +39 | +2.2% | 8,900 |
| 2023/03/29 | 1,790 | 1,806 | 1,790 | 1,806 | +4 | +0.2% | 3,200 |
| 2023/03/28 | 1,797 | 1,810 | 1,797 | 1,802 | -1 | -0.1% | 3,000 |
| 2023/03/27 | 1,795 | 1,807 | 1,791 | 1,803 | +27 | +1.5% | 3,800 |
| 2023/03/24 | 1,770 | 1,776 | 1,770 | 1,776 | +4 | +0.2% | 1,600 |
| 2023/03/23 | 1,764 | 1,780 | 1,763 | 1,772 | +8 | +0.5% | 2,500 |
| 2023/03/22 | 1,773 | 1,773 | 1,752 | 1,764 | +12 | +0.7% | 5,300 |
| 2023/03/20 | 1,757 | 1,775 | 1,744 | 1,752 | -45 | -2.5% | 5,800 |
| 2023/03/17 | 1,770 | 1,815 | 1,770 | 1,797 | +27 | +1.5% | 3,400 |
| 2023/03/16 | 1,765 | 1,775 | 1,764 | 1,770 | -12 | -0.7% | 2,200 |
| 2023/03/15 | 1,771 | 1,804 | 1,771 | 1,782 | +11 | +0.6% | 4,500 |
| 2023/03/14 | 1,784 | 1,784 | 1,768 | 1,771 | -26 | -1.4% | 3,500 |
| 2023/03/13 | 1,801 | 1,801 | 1,783 | 1,797 | -4 | -0.2% | 4,500 |
| 2023/03/10 | 1,793 | 1,807 | 1,792 | 1,801 | +2 | +0.1% | 8,500 |
| 2023/03/09 | 1,798 | 1,799 | 1,787 | 1,799 | +5 | +0.3% | 2,500 |
| 2023/03/08 | 1,791 | 1,794 | 1,783 | 1,794 | +3 | +0.2% | 3,000 |
| 2023/03/07 | 1,797 | 1,798 | 1,790 | 1,791 | -8 | -0.4% | 1,400 |
| 2023/03/06 | 1,799 | 1,803 | 1,790 | 1,799 | +6 | +0.3% | 5,400 |
| 2023/03/03 | 1,772 | 1,800 | 1,772 | 1,793 | +21 | +1.2% | 4,700 |
| 2023/03/02 | 1,766 | 1,783 | 1,766 | 1,772 | -15 | -0.8% | 3,300 |
| 2023/03/01 | 1,761 | 1,796 | 1,761 | 1,787 | +39 | +2.2% | 10,700 |
| 2023/02/28 | 1,755 | 1,755 | 1,746 | 1,748 | -13 | -0.7% | 2,400 |
| 2023/02/27 | 1,755 | 1,761 | 1,750 | 1,761 | +21 | +1.2% | 4,800 |
| 2023/02/24 | 1,742 | 1,744 | 1,738 | 1,740 | -2 | -0.1% | 1,500 |
| 2023/02/22 | 1,739 | 1,748 | 1,738 | 1,742 | -2 | -0.1% | 1,900 |
| 2023/02/21 | 1,755 | 1,755 | 1,743 | 1,744 | +1 | +0.1% | 2,400 |
| 2023/02/20 | 1,733 | 1,756 | 1,733 | 1,743 | +20 | +1.2% | 2,500 |
| 2023/02/17 | 1,732 | 1,735 | 1,723 | 1,723 | -4 | -0.2% | 800 |
| 2023/02/16 | 1,732 | 1,737 | 1,719 | 1,727 | -10 | -0.6% | 6,200 |
| 2023/02/15 | 1,737 | 1,742 | 1,727 | 1,737 | -17 | -1% | 4,400 |
| 2023/02/14 | 1,729 | 1,762 | 1,727 | 1,754 | +8 | +0.5% | 5,600 |
| 2023/02/13 | 1,750 | 1,753 | 1,735 | 1,746 | ±0 | ±0% | 6,100 |
| 2023/02/10 | 1,731 | 1,763 | 1,730 | 1,746 | +15 | +0.9% | 7,000 |
| 2023/02/09 | 1,737 | 1,741 | 1,731 | 1,731 | -6 | -0.3% | 5,800 |
| 2023/02/08 | 1,706 | 1,737 | 1,706 | 1,737 | +26 | +1.5% | 1,400 |
| 2023/02/07 | 1,712 | 1,725 | 1,711 | 1,711 | ±0 | ±0% | 4,100 |
| 2023/02/06 | 1,708 | 1,711 | 1,700 | 1,711 | +3 | +0.2% | 1,200 |
| 2023/02/03 | 1,703 | 1,714 | 1,700 | 1,708 | +2 | +0.1% | 2,700 |
| 2023/02/02 | 1,720 | 1,720 | 1,690 | 1,706 | -2 | -0.1% | 6,600 |
| 2023/02/01 | 1,734 | 1,734 | 1,693 | 1,708 | -80 | -4.5% | 12,000 |
| 2023/01/31 | 1,760 | 1,789 | 1,760 | 1,788 | +33 | +1.9% | 5,100 |
| 2023/01/30 | 1,758 | 1,787 | 1,755 | 1,755 | +9 | +0.5% | 20,900 |
| 2023/01/27 | 1,749 | 1,755 | 1,742 | 1,746 | ±0 | ±0% | 3,000 |
| 2023/01/26 | 1,740 | 1,758 | 1,733 | 1,746 | +9 | +0.5% | 6,600 |
| 2023/01/25 | 1,723 | 1,738 | 1,709 | 1,737 | +13 | +0.8% | 8,900 |
| 2023/01/24 | 1,714 | 1,725 | 1,702 | 1,724 | +10 | +0.6% | 5,700 |
| 2023/01/23 | 1,718 | 1,729 | 1,703 | 1,714 | -1 | -0.1% | 4,000 |
551～
600
件表示中 / 3733件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 150,600円 | +7.5% | -77.4% | 3.32% | 36.23倍 | 0.29倍 |
|
後発薬中堅、検査薬事業が第２の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
| ＤＥＬＴＡ－Ｐ | 64,400円 | - | - | 0.00% | - | 27.54倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| ティムス | 15,400円 | - | - | 0.00% | - | 2.53倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| カルナバイオ | 32,700円 | +13.5% | - | 0.00% | - | 2.61倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| サイフューズ | 72,200円 | +459.3% | - | 0.00% | - | 2.32倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
市場注目の銘柄
チャート関連のコラム
